225 related articles for article (PubMed ID: 32980497)
21. High linear energy transfer carbon-ion irradiation upregulates PD-L1 expression more significantly than X-rays in human osteosarcoma U2OS cells.
Permata TBM; Sato H; Gu W; Kakoti S; Uchihara Y; Yoshimatsu Y; Sato I; Kato R; Yamauchi M; Suzuki K; Oike T; Tsushima Y; Gondhowiardjo S; Ohno T; Yasuhara T; Shibata A
J Radiat Res; 2021 Sep; 62(5):773-781. PubMed ID: 34196706
[TBL] [Abstract][Full Text] [Related]
22.
Baniel CC; Heinze CM; Hoefges A; Sumiec EG; Hank JA; Carlson PM; Jin WJ; Patel RB; Sriramaneni RN; Gillies SD; Erbe AK; Schwarz CN; Pieper AA; Rakhmilevich AL; Sondel PM; Morris ZS
Front Immunol; 2020; 11():1610. PubMed ID: 32849544
[TBL] [Abstract][Full Text] [Related]
23. Tumors Resistant to Checkpoint Inhibitors Can Become Sensitive after Treatment with Vascular Disrupting Agents.
Horsman MR; Wittenborn TR; Nielsen PS; Elming PB
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32640548
[TBL] [Abstract][Full Text] [Related]
24. Carbon ion irradiation plus CTLA4 blockade elicits therapeutic immune responses in a murine tumor model.
Hartmann L; Osen W; Eichmüller OL; Kordaß T; Furkel J; Dickes E; Reid C; Debus J; Brons S; Abdollahi A; Moustafa M; Rieken S; Eichmüller SB
Cancer Lett; 2022 Dec; 550():215928. PubMed ID: 36183858
[TBL] [Abstract][Full Text] [Related]
25. Combination immunotherapy and radiotherapy causes an abscopal treatment response in a mouse model of castration resistant prostate cancer.
Dudzinski SO; Cameron BD; Wang J; Rathmell JC; Giorgio TD; Kirschner AN
J Immunother Cancer; 2019 Aug; 7(1):218. PubMed ID: 31412954
[TBL] [Abstract][Full Text] [Related]
26. Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors.
Ratti C; Botti L; Cancila V; Galvan S; Torselli I; Garofalo C; Manara MC; Bongiovanni L; Valenti CF; Burocchi A; Parenza M; Cappetti B; Sangaletti S; Tripodo C; Scotlandi K; Colombo MP; Chiodoni C
Clin Cancer Res; 2017 Sep; 23(17):5149-5161. PubMed ID: 28600479
[No Abstract] [Full Text] [Related]
27. Radiosensitization of NSCLC cells to X-rays and carbon ions by the CHK1/CHK2 inhibitor AZD7762, Honokiol and Tunicamycin.
Liu B; Chen W; Li H; Li F; Jin X; Li Q
Radiat Environ Biophys; 2020 Nov; 59(4):723-732. PubMed ID: 32857208
[TBL] [Abstract][Full Text] [Related]
28. Radiation Dose Escalation is Crucial in Anti-CTLA-4 Antibody Therapy to Enhance Local and Distant Antitumor Effect in Murine Osteosarcoma.
Takenaka W; Takahashi Y; Tamari K; Minami K; Katsuki S; Seo Y; Isohashi F; Koizumi M; Ogawa K
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32545427
[TBL] [Abstract][Full Text] [Related]
29. Enhancing the abscopal effect of radiation and immune checkpoint inhibitor therapies with magnetic nanoparticle hyperthermia in a model of metastatic breast cancer.
Oei AL; Korangath P; Mulka K; Helenius M; Coulter JB; Stewart J; Velarde E; Crezee J; Simons B; Stalpers LJA; Kok HP; Gabrielson K; Franken NAP; Ivkov R
Int J Hyperthermia; 2019 Nov; 36(sup1):47-63. PubMed ID: 31795835
[No Abstract] [Full Text] [Related]
30. Non-thermal histotripsy tumor ablation promotes abscopal immune responses that enhance cancer immunotherapy.
Qu S; Worlikar T; Felsted AE; Ganguly A; Beems MV; Hubbard R; Pepple AL; Kevelin AA; Garavaglia H; Dib J; Toma M; Huang H; Tsung A; Xu Z; Cho CS
J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31940590
[TBL] [Abstract][Full Text] [Related]
31. Immune checkpoint inhibition combined with targeted therapy using a novel virus-like drug conjugate induces complete responses in a murine model of local and distant tumors.
Huis In 't Veld RV; Ma S; Kines RC; Savinainen A; Rich C; Ossendorp F; Jager MJ
Cancer Immunol Immunother; 2023 Jul; 72(7):2405-2422. PubMed ID: 36997666
[TBL] [Abstract][Full Text] [Related]
32. Th Balance-Related Host Genetic Background Affects the Therapeutic Effects of Combining Carbon-Ion Radiation Therapy With Dendritic Cell Immunotherapy.
Ma L; Sakamoto Y; Ando K; Fujita H; Takahashi A; Takeshima T; Otsuka H; Ebner DK; Kakimi K; Imai T; Shimokawa T
Int J Radiat Oncol Biol Phys; 2022 Mar; 112(3):780-789. PubMed ID: 34740767
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of antitumor immune response by radiation therapy combined with dual immune checkpoint inhibitor in a metastatic model of HER2-positive murine tumor.
Misaki S; Murata S; Shimoji M; Iwai T; Sihombing AM; Aoki K; Takahashi Y; Watanabe Y
Jpn J Radiol; 2022 Dec; 40(12):1307-1315. PubMed ID: 35763240
[TBL] [Abstract][Full Text] [Related]
34. Intravenous dendritic cell administration enhances suppression of lung metastasis induced by carbon-ion irradiation.
Ando K; Fujita H; Hosoi A; Ma L; Wakatsuki M; Seino KI; Kakimi K; Imai T; Shimokawa T; Nakano T
J Radiat Res; 2017 Jul; 58(4):446-455. PubMed ID: 28339788
[TBL] [Abstract][Full Text] [Related]
35. Radiation Enhances the Efficacy of Antitumor Immunotherapy with an Immunocomplex of Interleukin-2 and Its Monoclonal Antibody.
Takahashi Y; Yasui T; Minami K; Tamari K; Otani K; Seo Y; Isohashi F; Koizumi M; Ogawa K
Anticancer Res; 2017 Dec; 37(12):6799-6806. PubMed ID: 29187458
[TBL] [Abstract][Full Text] [Related]
36. The future of radiation-induced abscopal response: beyond conventional radiotherapy approaches.
Tubin S; Yan W; Mourad WF; Fossati P; Khan MK
Future Oncol; 2020 Jun; 16(16):1137-1151. PubMed ID: 32338046
[TBL] [Abstract][Full Text] [Related]
37. Low-Dose Radiation Potentiates the Propagation of Anti-Tumor Immunity against Melanoma Tumor in the Brain after In Situ Vaccination at a Tumor outside the Brain.
Clark PA; Sriramaneni RN; Bates AM; Jin WJ; Jagodinsky JC; Hernandez R; Le T; Jeffery JJ; Marsh IR; Grudzinski JJ; Aluicio-Sarduy E; Barnhart TE; Anderson BR; Chakravarty I; Arthur IS; Kim K; Engle JW; Bednarz BP; Weichert JP; Morris ZS
Radiat Res; 2021 Jun; 195(6):522-540. PubMed ID: 33826741
[TBL] [Abstract][Full Text] [Related]
38. Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses.
Caetano MS; Younes AI; Barsoumian HB; Quigley M; Menon H; Gao C; Spires T; Reilly TP; Cadena AP; Cushman TR; Schoenhals JE; Li A; Nguyen QN; Cortez MA; Welsh JW
Clin Cancer Res; 2019 Dec; 25(24):7576-7584. PubMed ID: 31540976
[TBL] [Abstract][Full Text] [Related]
39. In situ vaccination at a peripheral tumor site augments response against melanoma brain metastases.
Clark PA; Sriramaneni RN; Jin WJ; Jagodinsky JC; Bates AM; Jaquish AA; Anderson BR; Le T; Lubin JA; Chakravarty I; Arthur IS; Heinze CM; Guy EI; Kler J; Klar KA; Carlson PM; Kim KM; Kuo JS; Morris ZS
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32690669
[TBL] [Abstract][Full Text] [Related]
40. Multicenter Evaluation of the Tolerability of Combined Treatment With PD-1 and CTLA-4 Immune Checkpoint Inhibitors and Palliative Radiation Therapy.
Bang A; Wilhite TJ; Pike LRG; Cagney DN; Aizer AA; Taylor A; Spektor A; Krishnan M; Ott PA; Balboni TA; Hodi FS; Schoenfeld JD
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):344-351. PubMed ID: 28463153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
